Six Ingredient Trials, No Trial Of The Blend: Reading Alpha Erec’s Evidence As A Whole

Last updated September 2026 12 min read Ingredient research

Every other article on this blog reads one ingredient at a time. This one steps back and reads all six together, as a set of six separate research literatures rather than one body of evidence for the gummy. No trial has tested the finished Alpha Erec product, in anyone, at any dose. This article sets out exactly what has been tested instead, and what that gap does and does not mean.

Why every trial here tested one ingredient

Every figure on this blog, the risk ratios, the odds ratios, the milligram doses, comes from a trial that gave people one substance and compared it with a placebo. That is not an oversight. It is how this kind of research is normally built: give one thing, change one variable, and you can say that substance, at that dose, produced that result. Give six things at once and a trial can no longer tell you which of the six did what, or whether they added to, cancelled out, or left each other alone.

There is also a plainer, commercial reason no one has run a trial of the finished six-ingredient blend. Dietary supplements in the United States are regulated under a framework that does not require a manufacturer to prove the finished product works before selling it, the way a medicine must. The FTC’s own guidance on health-product marketing exists precisely because that gap between what is legal to sell and what has been proven is where most misleading claims live. A combined-product trial is expensive, slow, and not required, so for a six-ingredient gummy, it has simply not been done.

Six trials, side by side

Setting all six side by side, rather than one at a time, makes a pattern visible that no single ingredient article shows on its own.

The population problem

Five of the six rows above studied adult men, which is who Alpha Erec is sold to. The sixth, horny goat weed, has exactly one controlled human study, and it enrolled 58 post-menopausal women averaging almost 58 years old, to check bone markers rather than anything related to sexual performance or circulation. That single study is the entire human pharmacokinetic record for that ingredient; there is no equivalent study in men to set beside it.

This matters because sex, age and hormonal status genuinely change how a compound is absorbed, metabolised and how much of it reaches the tissues where it might act. A finding in a 58-year-old post-menopausal woman is not a stand-in for a 35-year-old man, and no source used on this site claims otherwise. The horny goat weed article goes through that one study in full.

The dose problem

Every dose in the table above is a research dose: the amount a trial gave, in milligrams or grams, over a stated number of weeks. Alpha Erec’s own ingredients page treats each of those figures as “the yardstick to hold your bottle’s facts panel against,” not as the amount inside a gummy. That is because no source available to this site publishes a milligram breakdown for any of the six named ingredients; the label states a serving of one gummy a day without an ingredient-by-ingredient amount.

That gap runs in both directions. A buyer cannot confirm that a gummy contains anywhere near 740 mg of horny goat weed extract, or 1,500 mg of maca, or several grams of L-arginine, because that figure has not been published. Equally, nobody should assume a gummy contains too little to matter; the honest position, on the evidence this site has, is that the amount is simply unknown, ingredient by ingredient.

The duration problem

The six trials above ran from six weeks (horny goat weed) to three months (tribulus, at the long end). None ran longer than that. Ashwagandha’s trial ran eight weeks; maca’s ran twelve. That range sets a reasonable window for judging any single ingredient’s short-term effect. It says nothing about six months or a year of daily use, of any of these ingredients, alone or together, because that data does not exist in the sources this site draws on.

What a trial of the finished blend would need to show

It is worth spelling out what a real test of the combined product would actually require, if anyone ran one: randomising a large enough group of adult men to either the finished Alpha Erec gummy, at its labelled one-a-day dose, or a matching placebo; keeping both the men and the researchers blind to who received which; running it for at least as long as the longest single-ingredient trial above, three months, and ideally longer; and measuring the same kind of outcome the individual-ingredient trials used, such as a validated erectile-function score, rather than a vaguer measure.

None of the six studies in the table did this, because none of them tested the blend. That is not a criticism of any one study; each did what it set out to do, for one ingredient. It is simply a description of what is, and is not, on record for the product as a whole.

Reading six literatures without over-reading them

1. 01

   Treat each figure as belonging to one ingredient, at one dose, in one group

   An odds ratio from a ginseng trial says something about ginseng, at the dose that trial used, in the men it enrolled. It is not automatically true of the finished gummy.

2. 02

   Do not add six small effects into one big one

   No study measured whether these six ingredients’ effects combine, cancel out, or do nothing extra together. Adding them up on paper is not the same as testing it.

3. 03

   Notice which population matches you

   Five ingredients were studied in adult men. One was studied in post-menopausal women, for an unrelated outcome. Weight the two kinds of evidence differently.

4. 04

   Use trial duration to set your own timeline

   The trials above ran six weeks to three months. That is a reasonable stretch to judge a single ingredient by; it is not evidence about a year of use.

Questions buyers ask

The short answer

Alpha Erec’s six named ingredients each carry their own body of human research, and reading them one at a time, as the rest of this blog does, is useful and honest as far as it goes. Read together, the gaps show: no trial of the finished blend, one ingredient studied in the wrong population for an unrelated outcome, no published per-gummy doses to compare against any of the research figures, and no data past three months. None of that means the ingredients do nothing. It means the finished product’s evidence is, and remains, the sum of six separate stories rather than one. Every one of those six stories, in full, is on the ingredients page.